What Is Alpha-1 Antitrypsin Deficiency?
Alpha-1
antitrypsin (AAT) is a
protein normally found in the lungs and the
bloodstream. It helps protect the lungs from diseases such as
emphysema and
chronic obstructive pulmonary disease (COPD). People
who do not make enough of this protein-this is called AAT deficiency-are more
likely to have these lung diseases and will get them at a younger-than-normal
age (30 to 40 years old). It can also damage the liver. AAT deficiency is a
rare disorder and is the only known
genetic (inherited) factor that increases your chances
for having lung diseases.
Alpha-1 antitrypsin deficiency is caused
by a change, or mutation, in the
gene that tells the body how to make alpha-1
antitrypsin. There are many kinds of possible changes in this gene, but only a
few cause problems. To have this condition, you have to get the changed gene
from both parents.
If you receive only one changed gene, you have
the changed gene but not the disease (you are a
carrier
). The good copy of the gene you received from
your other parent is enough to tell your body how to properly make alpha-1
antitrypsin. Some people who carry the changed gene may have very mild symptoms
of the deficiency.
Treatment for alpha-1 antitrypsin deficiency
mainly involves avoiding substances-especially cigarette smoke-that could harm
your lungs. Also try to avoid dust and workplace chemicals. You also may want
to avoid alcohol because of the risk of liver damage. Exercise can improve your
stamina and overall health.
The only treatment available for the
lack of the protein is
plasma containing alpha-1 antitrypsin. This is usually
given only to people who have very low levels of AAT in their blood. It is not
clear that this treatment is any better than avoiding smoke and other
lung-damaging chemicals. The plasma is made from the blood of many donors and
it is treated to reduce the chance of spreading an infectious disease. You
receive the plasma through an
IV, usually every 3 to 4 weeks for life.
What Is AAT Deficiency Testing?
A blood test can
measure the amount of alpha-1 antitrypsin (AAT) in your blood. You may have AAT
deficiency if your levels are low or if the blood test is not able to find any
AAT in your blood. If your AAT level is lower than normal, the blood sample can
be tested to look for the type of alpha-1 antitrypsin. People who carry the
changed gene may be more at risk for symptoms if they have a certain type of
alpha-1 antitrypsin.
Alpha-1 antitrypsin levels | Normal: | 85-213
mg/dL or 0.85-2.13
g/L |
|---|
Is Testing Accurate?
Although this blood test is
highly reliable, no test is 100% accurate. This test cannot predict when-or
whether-you will develop symptoms or how severe they will be.
Should I Be Tested?
The decision to have the test is
personal. You may have emotional, financial, and family reasons for taking or
not taking the test.
You may choose to have the test
because:
- You have unexplained lung problems and want to
know whether you have this condition.
- Other people in your family
have AAT deficiency.
- Other people in your family have unexplained
lung disease or liver disease.
- You want to take steps to protect
your health if you find out you have the condition.
- You would be
relieved to know that you do not have the changed gene.
- You would
change your decision about having children because of test
results.
- Your insurance would pay for the test.
Why Would I Not Be Tested?
You may decide not to be
tested because:
- You do not have symptoms of lung
disease.
- No one in your family has AAT deficiency or lung or liver
disease.
- You would be worried if you knew that you might get lung
or liver disease some day.
- You do not smoke and you already are
taking good care of yourself. You think there is nothing more you could do to
prevent or delay the disease.
- The test cannot predict whether you
will ever have symptoms of this condition.
- You do not have
insurance or your insurance would not pay for the test.
- You are
worried that the test results might cause problems for you at work or make it
hard for you to get health insurance.
What Is Genetic Counseling?
Information from genetic
testing can have a big impact on your life. Ask to have
genetic counseling before making a decision about
testing. Genetic counselors are trained to explain the test and its results,
but you make the decision about whether to have the test. A genetic counselor
can help you make well-informed decisions. Genetic counseling can help you and
your family:
- Understand medical facts, including what causes
diseases, how a diagnosis is made, and what you may be able to do to help you
manage a disease.
- Understand how your family history contributes to
the development of a disease.
- Help you learn about caring for a
family member with a genetic disease, including getting referrals to
specialists or joining support groups.
Genetic counselors are trained to help you and your family
make informed decisions. They are sensitive to the physical and emotional
aspects of these decisions. Your privacy and confidentiality are carefully
protected.
Other Places To Get Help
Organization
| Alpha-1 Foundation |
| 2937 SW 27th Avenue |
|
Suite 302 |
| Miami, FL 33133 |
| Phone: | 1-877-2-CURE-A1 (1-877-228-7321) toll-free (305) 567-9888 |
| Fax: | (305) 567-1317 |
| E-mail: | info@alphaone.org |
| Web Address: | www.alphaone.org |
| |
The Alpha-1 Foundation provides resources for people
with alpha-1 antitrypsin deficiency, a condition that is passed on from parents
to their children through genes. The foundation provides information on
standards for diagnosis and treatment, resources and information about alpha-1
antitrypsin deficiency and testing, clinical resource center locations,
research programs, special stories, and education opportunities. |
|
References
Other Works Consulted
Credits
| Author | Maria G. Essig, MS, ELS |
| Editor | Susan Van Houten, RN, BSN, MBA |
| Associate Editor | Tracy Landauer |
| Primary Medical Reviewer | Caroline S. Rhoads, MD - Internal Medicine |
| Specialist Medical Reviewer | Ken Y. Yoneda, MD - Pulmonology |
| Last Updated | May 8, 2008 |